| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.0M | — | -21.6% |
| Cost of Revenue | $3.1M | — | -24.5% |
| Gross Profit | $5.9M | — | -19.9% |
| R&D Expense | $153K | — | -13.6% |
| SG&A Expense | $2.5M | — | -3.9% |
| Operating Income | $1.1M | — | -38.6% |
| Interest Expense | $78K | — | +0.0% |
| Pre-tax Income | $1.1M | — | -36.1% |
| Income Tax | $302K | — | +1577.8% |
| Net Income | $721K | — | -56.2% |
| EPS (Basic) | $0.03 | — | -91.9% |
| EPS (Diluted) | $0.03 | — | -50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.6M | +5.7% | +121.3% |
| Accounts Receivable | $5.9M | +4.9% | -32.4% |
| Inventory | $961K | -13.7% | -20.5% |
| Current Assets | $10.0M | +0.6% | -14.5% |
| Total Assets | $33.4M | -1.3% | +130.5% |
| Current Liabilities | $4.0M | -22.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $283K | — | -77.1% |
| Capital Expenditures | $141K | — | — |
| Investing Cash Flow | -$141K | — | — |
| Financing Cash Flow | -$1.5M | — | +0.0% |
| Free Cash Flow | $142K | — | — |
| -54.3% |
| Total Liabilities | $10.3M | -10.0% | -31.5% |
| Stockholders' Equity | $23.1M | +3.2% | +4066.0% |